Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,817
Total Claims
$1.7M
Drug Cost
1,291
Beneficiaries
$1,283
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
+221%
Opioid rate vs peers
8.2% vs 2.6% avg
+4%
Cost per patient vs peers
$1,283 vs $1,237 avg
+27%
Brand preference vs peers
11.7% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 221% above Geriatric Medicine peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
8.2%
Opioid Rate
1,630
Opioid Claims
$66K
Opioid Cost
12.2%
Long-Acting Rate
Brand vs Generic
Brand: 2,300 claims · $1.3M
Generic: 17,409 claims · $384K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 303 | $201K |
| Rivaroxaban | 106 | $105K |
| Empagliflozin | 79 | $98K |
| Semaglutide | 71 | $88K |
| Insulin Glargine,hum.Rec.Anlog | 91 | $57K |
| Mirabegron | 94 | $51K |
| Fluticasone/Umeclidin/Vilanter | 56 | $43K |
| Liraglutide | 15 | $42K |
| Rifaximin | 22 | $32K |
| Sitagliptin Phosphate | 13 | $22K |
| Oxycodone Hcl | 21 | $21K |
| Hydrocodone/Acetaminophen | 664 | $20K |
| Linagliptin | 13 | $19K |
| Insulin Detemir | 34 | $18K |
| Insulin Aspart | 33 | $18K |
Prescribing Profile
Patient Profile
76
Avg Age
55%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About